Deutsche Bank Lifts Price Target on Elevance Health to $363 From $332, Keeps Hold Rating
Elevance Health (ELV) has an average rating of overweight and mean price target of $376.24, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $339.04, Change: $+10.84, Percent Change: +3.30%